ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow Reinvestment Rate
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Reinvestment Rate of 0.15x as of March 2026, reinvesting $5.21 Million (capex $5.21 Million ) from operating cash flow of $33.98 Million. Explore ACAD capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ACADIA Pharmaceuticals Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for ACADIA Pharmaceuticals Inc across 3 annual periods. Also explore ACAD current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year capital reinvestment analysis for ACADIA Pharmaceuticals Inc. For live market cap and broader valuation context, see ACAD company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.85x | $203.73 Million | $109.84 Million | $4.69 Million | ▲ +841.8% |
| 2024 | 0.20x | $31.06 Million | $157.72 Million | $523.00K | ▼ -95.4% |
| 2023 | 4.31x | $72.05 Million | $16.70 Million | $40.05 Million | — |